* Reflects the 2-for-1 stock split effective June 1999 and the 3-for-2
stock split effective September 1998.
(1) Net income and net income per share include purchased research and
development expenses of $81 million. Pro forma net income and net income per
share, excluding this nonrecurring item net of tax, would have been $727 million
and $0.21, respectively.
(2) Net income and net income per share include purchased research and
development expenses of $349 million. Pro forma net income and net income per
share, excluding this nonrecurring item net of tax, would have been $611 million
and $0.18, respectively.
(3) Net income and net income per share include purchased research and
development expenses of $41 million. Pro forma net income and net income per
share, excluding this nonrecurring item net of tax, would have been $560 million
and $0.17, respectively.
(4) Net income and net income per share include purchased research and
development expenses of $48 million. Pro forma net income and net income per
share, excluding this nonrecurring item net of tax, would have been $525 million
and $0.16, respectively.
(5) Net income and net income per share include purchased research and
development expenses of $419 million. Pro forma net income and net income per
share, excluding this nonrecurring item net of tax, would have been $486 million
and $0.15, respectively.
(6) Net income and net income per share include purchased research and
development expenses of $127 million and realized gains on the sale of a minority
stock investment of $5 million. Pro forma net income and diluted net income per
share, excluding these nonrecurring items net of tax, would have been
$417 million and $0.13, respectively.
